➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
Medtronic
Harvard Business School
Dow
Express Scripts

Last Updated: September 22, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for Parnaparin


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Parnaparin?

Parnaparin is an investigational drug.

There have been 3 clinical trials for Parnaparin. The most recent clinical trial was a Phase 3 trial, which was initiated on August 1st 2006.

The most common disease conditions in clinical trials are Venous Thrombosis, Thrombosis, and Thrombophlebitis. The leading clinical trial sponsors are Università degli Studi dell'Insubria, Alfa Wassermann, Bologna, Italy, and St. Orsola Hospital.

Recent Clinical Trials for Parnaparin
TitleSponsorPhase
Weight Adjusted Low Molecular Weight Heparin in Recurrent Implantation Failure: a Randomized Open Labeled TrialIstituto Clinico HumanitasPhase 3
Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein ThrombosisSt. Orsola HospitalPhase 3
Parnaparin vs Aspirin in the Treatment of Retinal Vein OcclusionAlfa Wassermann, Bologna, ItalyPhase 3

See all Parnaparin clinical trials

Clinical Trial Summary for Parnaparin

Top disease conditions for Parnaparin
Top clinical trial sponsors for Parnaparin

See all Parnaparin clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Dow
Colorcon
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.